Biotech, Food & Drug

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Nov
3
2023
Medical Marketer Convicted of $55 Million Fraud Scheme ArentFox Schiff LLP
Nov
2
2023
FDA Proposes Rule to Prohibit Brominated Vegetable Oil in Food Keller and Heckman LLP
Nov
2
2023
Diagnosing Health Care Podcast – Episode 71: Dietary Supplements – Navigating the Regulatory Maze [Podcast] Epstein Becker & Green, P.C.
Nov
1
2023
PFAS in Consumer Products: CPSC Requests Input Keller and Heckman LLP
Nov
1
2023
FDA Issued a Proposed Rule to Amend Prior Notice Regulation Keller and Heckman LLP
Nov
1
2023
PFAS Consumer Fraud Lawsuit Update: New Protein Supplement Case In NY CMBG3 Law
Oct
31
2023
FDA Seeks Comments on Revised Draft Guidance for Communicating Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Keller and Heckman LLP
Oct
31
2023
The Haunting in the Cornfield: Relators’ Qui Tam Claim Confirmed Dead by the Eighth Circuit Bradley Arant Boult Cummings LLP
Oct
31
2023
This is the End: Alabama Medical Cannabis Commission Sets End Game Scenario – Will it Work? Bradley Arant Boult Cummings LLP
Oct
31
2023
FDA: New Draft Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Products Foley & Lardner LLP
Oct
30
2023
Alcohol Industry M&A: Common Pitfalls for Founders (and Avoiding Them) Part One: Formulas and Processes McDermott Will & Emery
Oct
30
2023
District Courts Apply Ninth Circuit Precedent to Dismiss Deceptive Labelling Claims Foley & Lardner LLP
Oct
30
2023
Guidance from FDA Clarifies a Key Issue for Industry: Non-Promotional Presentations About Unapproved Uses of Medical Products Can Be Produced by the Products’ Sponsors Without Violating Off-Label Rules Mintz
Oct
30
2023
High Protections on Information Relating to Employees’ Cannabis Use Sheppard, Mullin, Richter & Hampton LLP
Oct
30
2023
Fast 5: Five Quick Regulatory Takeaways for Pharmaceutical Companies ArentFox Schiff LLP
Oct
30
2023
FDA’s New Enforcement Policy: A Win for Remote Patient Monitoring and Remote Therapeutic Monitoring Manufacturers Foley & Lardner LLP
Oct
30
2023
Study Finds One-Third of Chocolate Contains High Levels of Heavy Metals Keller and Heckman LLP
Oct
30
2023
Compensation for Food Handler Certification in California Jackson Lewis P.C.
Oct
27
2023
HRSA Issues Notice Confirming 340B Registration Requirement McDermott Will & Emery
Oct
27
2023
New Antidumping and Countervailing Petitions on Frozen Warmwater Shrimp from Ecuador, India, Indonesia, and Vietnam ArentFox Schiff LLP
Oct
26
2023
GT Legal Food Talk Episode 22: Supplementing Your Pet’s Lifestyle with Bill Bookout and the National Animal Supplement Council Greenberg Traurig, LLP
Oct
26
2023
FDA Issues New Warning Regarding Compounded Ketamine Foley & Lardner LLP
Oct
26
2023
Big Law Redefined: Episode 9 | Beware, New Beauty Brands! Greenberg Traurig, LLP
Oct
25
2023
NanoHarmony Publishes White Paper on OECD Test Guideline Development Bergeson & Campbell, P.C.
Oct
25
2023
Connecticut Follows in the Footsteps of Other Jurisdictions Requiring Registration of Pharmaceutical Representatives Sheppard, Mullin, Richter & Hampton LLP
Oct
25
2023
California Bans Several FDA-Authorized Food Additives; New York May Soon Follow ArentFox Schiff LLP
Oct
25
2023
DEA Further Extends Flexibilities for Controlled-Substance Prescribing Via Telemedicine McDermott Will & Emery
Oct
25
2023
FDA Publishes FY 2021 Pesticide Residue Report Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins